We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




FIND Receives Grant for Diagnostics from Dutch Government

By Labmedica staff writers
Posted on 29 Nov 2006
The Dutch Government has approved the Foundation for Innovative New Diagnostics' (FIND, Geneva, Switzerland) application for a grant to develop improved diagnostics for tuberculosis (TB), the human immunodeficiency virus (HIV), and malaria. More...


The grant amounts to U.S.$10.1 million over a period of four years, beginning November 2006. The grant is to finance gaps in existing plans and programs to develop simple, accurate, and rapid molecular tests for TB, HIV, and malaria.

The point-of-care products to be developed by FIND will include chemical sensor arrays for the detection of volatile compounds in the sputum of TB infected individuals, an improved lateral-flow assay to diagnose malaria in a finger-prick blood sample, and a lateral-flow assay to diagnose TB by detecting Mycobacterium tuberculosis (MTb) antigens in urine.

FIND also plans to develop a simple nucleic acid amplification test for the detection of TB in urine, a simple amplification test for the detection of malaria from whole blood, and a hands-free automated nucleic acid amplification test (NAAT) for HIV viral load in blood at first-referral laboratory level.

In the first quarter of 2007 FIND plans to launch a project on laboratory preparedness for the introduction of new technologies in Uganda, with the aim to strengthen laboratory diagnostic services in that country.




Related Links:
FIND

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
HPV Test
Allplex HPV28 Detection
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The automated multiplex PCR assay runs on the BioFire Spotfire Vaginitis System, bringing molecular vaginitis testing to the point of care (Photo courtesy of bioMérieux)

Molecular Vaginitis Panel Gains FDA Clearance and CLIA Waiver for Point-of-Care Use

Vaginitis affects most women at least once in their lifetime and can cause painful, disruptive symptoms. Common causes include bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis, reflecting... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image: The CE-marked software IVD combines digital histopathology and clinicopathological data to generate a prognostic classification (Image Credit: Shutterstock)

Digital Pathology Test Stratifies Recurrence Risk in Early Breast Cancer

In hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative early breast cancer, accurate recurrence-risk assessment helps guide treatment decisions. However, individual risks... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.